Hematopoetic stem cell transplantation for immune thrombocytopenia and other refractory autoimmune cytopenias

References

• Bussel JB. Overview of idiopathic thrombocytopenic purpura: New approach to refractory patients. Semin Oncol 2000; 27(6 Suppl 12)91–98
   PubMedGoogle Scholar
• Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346(13)995–1008
   PubMed Web of Science ®Google Scholar
• van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20(1)10–16
   PubMed Web of Science ®Google Scholar
• Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 2001; 29(6)661–669
   PubMed Web of Science ®Google Scholar
• Marmont AM, Gualandi F, Van Lint MT, Bacigalupo A. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect. Bone Marrow Transplant 2003; 31(5)399–402
   PubMed Web of Science ®Google Scholar
• Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol 2000; 28(7)853–857
   PubMedGoogle Scholar
• Tyndall A, Fassas A, Passweg J, et al. Autologous haematopoietic stem cell transplants for autoimmune disease—feasibility and transplant-related mortality. Autoimmune disease and lymphoma working parties of the European group for blood and marrow transplantation, the European league against rheumatism and the international stem cell project for autoimmune disease. Bone Marrow Transplant 1999; 24(7)729–734
   PubMedGoogle Scholar
• Binks M, Passweg JR, Furst D, et al. Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease. Ann Rheum Dis 2001; 60(6)577–584
   PubMed Web of Science ®Google Scholar
• Fassas A, Passweg JR, Anagnostopoulos A, et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. J Neurol 2002; 249(8)1088–1097
   PubMed Web of Science ®Google Scholar
• Jayne D, Passweg J, Marmont A, et al. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 2004; 13(3)168–176
   PubMed Web of Science ®Google Scholar
• Traynor AE, Schroeder J, Rosa RM, et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase I study. Lancet 2000; 356(9231)701–707
   PubMed Web of Science ®Google Scholar
• Snowden JA, Passweg J, Moore JJ, et al. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: A report from the EBMT and ABMTR. J Rheumatol 2004; 31(3)482–488
   PubMed Web of Science ®Google Scholar
• Huhn RD, Fogarty PF, Nakamura R, et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia. Blood 2003; 101(1)71–77
   PubMed Web of Science ®Google Scholar
• Passweg JR, Rabusin M, Musso M, et al. Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004; 125(6)749–755
   PubMedGoogle Scholar
• Skoda RC, Tichelli A, Tyndall A. Autologous peripheral blood stem cell transplantation in a patient with chronic autoimmune thrombocytopenia. Br J Haematol 1997; 99(1)56–57
   PubMedGoogle Scholar
• Seeliger S, Baumann M, Mohr M, et al. Autologous peripheral blood stem cell transplantation and anti-B-cell directed immunotherapy for refractory auto-immune haemolytic anaemia. Eur J Pediatr 2001; 160(8)492–496
   PubMedGoogle Scholar
• Marmont AM, van Lint MT, Occhini D, et al. Failure of autologous stem cell transplantation in refractory thrombocytopenic purpura. Bone Marrow Transplant 1998; 22(8)827–828
   PubMedGoogle Scholar
• Lim SH, Kell J, Al-Sabah A, et al. Peripheral blood stem-cell transplantation for refractory autoimmune thrombocytopenic purpura. Lancet 1997; 349(9050)475
   PubMedGoogle Scholar
• Marmont AM, Gualandi F, Occhini D. Catastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome. Autoimmunity 2006; 39(6)505–511
   PubMed Web of Science ®Google Scholar
• Musso M, Porretto F, Crescimanno A, et al. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 2004; 33(7)769–771
   PubMedGoogle Scholar
• Urban C, Lackner H, Sovinz P. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation. Eur J Haematol 2006; 76(6)526–530
   PubMed Web of Science ®Google Scholar
• Caselli D, Farruggia P, Trizzino A, et al. Split chimerism may be enough to cure Evans syndrome. Bone Marrow Transplant 2006; 38(4)311
   PubMedGoogle Scholar
• Demirer T, Celebi H, Arat M. Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1999; 24(3)335–337
   PubMedGoogle Scholar
• Jindra P, Koza V, Fiser J, et al. Autologous CD34+ cells transplantation after FAMP treatment in a patient with CLL and persisting AIHA: Complete remission of lymphoma with control of autoimmune complications. Bone Marrow Transplant 1999; 24(2)215–217
   PubMedGoogle Scholar